氡暴露、克隆性造血与女性健康倡议中的卒中易感性
本研究将10,799名女性健康倡议参与者地址链接至美国环境保护署预测的县级室内氡浓度,分析氡暴露与不明潜能克隆性造血(CHIP)风险的关联。在缺血性卒中患者中,氡暴露与CHIP风险升高相关,尤其在心源性栓塞型卒中中关联更强。
要点
- 在缺血性卒中参与者中,氡暴露与CHIP风险升高相关。
- 心源性栓塞型卒中亚组中氡与CHIP的关联估计值更高。
- 出血性卒中或无卒中参与者中未观察到显著关联。
核心结论
- 在发生心源性栓塞型卒中的绝经后女性中,氡相关CHIP风险稳健升高,提示体细胞基因组突变可能在该脑血管病中起作用,但机制尚未证实。
研究设计与样本
- 将10,799名女性健康倡议Trans-Omics for Precision Medicine参与者的地理编码地址链接至美国环境保护署预测的县级室内平均筛查氡浓度,按Zone 1(>4 pCi/L)、Zone 2(2-4 pCi/L)、Zone 3(<2 pCi/L)分类。
- CHIP定义为存在一个或多个白血病驱动突变且变异等位基因频率>0.02,识别 prevalent 和 incident 缺血性与出血性卒中,缺血性卒中按TOAST标准分型,使用多变量调整的设计加权逻辑回归估计OR和95%CI。
主要发现
- Zone 1、2、3参与者中CHIP百分比分别为9.0%、8.4%、7.7%(ptrend=0.06)。
- 在缺血性卒中参与者中,相对于Zone 3,Zone 2和Zone 1的CHIP估计风险分别为1.39(1.15-1.68)和1.46(1.15-1.87)。
- 在出血性卒中参与者中,Zone 2和Zone 1的OR分别为0.98(0.68-1.40)和1.03(0.70-1.52);无卒中参与者分别为1.04(0.74-1.46)和0.95(0.63-1.42)(pinteraction=0.03)。
- TOAST分型心源性栓塞亚组中,Zone 2和Zone 1的OR分别为1.78(1.30-2.47)和1.88(1.31-2.72);其他缺血性病因亚组分别为1.37(1.06-1.78)和1.50(1.11-2.04);小血管闭塞亚组分别为1.05(0.74-1.49)和1.00(0.68-1.47)(pinteraction=0.10)。
关键数值与推荐
- CHIP定义为存在一个或多个白血病驱动突变且变异等位基因频率>0.02。
- 氡浓度分类:Zone 1(>4 pCi/L)、Zone 2(2-4 pCi/L)、Zone 3(<2 pCi/L)。
- 缺血性卒中按TOAST标准分型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 机制尚未证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Studies suggest that clonal hematopoiesis of indeterminate potential (CHIP) may increase risk of hematologic malignancy and cardiovascular disease, including stroke. However, few studies have investigated plausible environmental risk factors for CHIP such as radon, despite the climate-related increases in and documented infrequency of testing for this common indoor air pollutant.The purpose of this study was to estimate the risk of CHIP related to radon, an established environmental mutagen. METHODS: We linked geocoded addresses of 10,799 Women's Health Initiative Trans-Omics for Precision Medicine (WHI TOPMed) participants to US Environmental Protection Agency-predicted, county-level, indoor average screening radon concentrations, categorized as follows: Zone 1 (>4 pCi/L), Zone 2 (2-4 pCi/L), and Zone 3 (<2 pCi/L). We defined CHIP as the presence of one or more leukemogenic driver mutations with variant allele frequency >0.02. We identified prevalent and incident ischemic and hemorrhagic strokes; subtyped ischemic stroke using Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria; and then estimated radon-related risk of CHIP as an odds ratio (OR) and 95% CI using multivariable-adjusted, design-weighted logistic regression stratified by age, race/ethnicity, smoking status, and stroke type/subtype. RESULTS: The percentages of participants with CHIP in Zones 1, 2, and 3 were 9.0%, 8.4%, and 7.7%, respectively (ptrend = 0.06). Among participants with ischemic stroke, Zones 2 and 1 were associated with higher estimated risks of CHIP relative to Zone 3: 1.39 (1.15-1.68) and 1.46 (1.15-1.87), but not among participants with hemorrhagic stroke: 0.98 (0.68-1.40) and 1.03 (0.70-1.52), or without stroke: 1.04 (0.74-1.46) and 0.95 (0.63-1.42), respectively (pinteraction = 0.03). Corresponding estimates were particularly high among TOAST-subtyped cardioembolism: 1.78 (1.30-2.47) and 1.88 (1.31-2.72), or other ischemic etiologies: 1.37 (1.06-1.78) and 1.50 (1.11-2.04), but not small vessel occlusion: 1.05 (0.74-1.49) and 1.00 (0.68-1.47), respectively (pinteraction = 0.10). Observed patterns of association among strata were insensitive to attrition weighting, ancestry adjustment, prevalent stroke exclusion, separate analysis of DNMT3A driver mutations, and substitution with 3 alternative estimates of radon exposure. DISCUSSION: The robust elevation of radon-related risk of CHIP among postmenopausal women who develop incident cardioembolic stroke is consistent with a potential role of somatic genomic mutation in this societally burdensome form of cerebrovascular disease, although the mechanism has yet to be confirmed.
引用
- Anthony KM, Collins JM, Love SM, et al. Radon Exposure, Clonal Hematopoiesis, and Stroke Susceptibility in the Women's Health Initiative. Neurology. 2024. PMID: 38170948. doi:10.1212/WNL.0000000000208055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。